Steve Holmes
COO, Chief Operating Officer
Global Medicines Development
Capellabioscience
United Kingdom
Biography
Steve was an Assistant Professor of Urology at Baylor College of Medicine, and has a BSc in physiology and organic chemistry and a PhD in Endocrinology from the University of Sheffield. He has more than 60 research publications including papers in Nature and has over 40 patents.He was also at SmithKline Beecham and GSK for 11 years initially heading the monoclonal antibody group and leaving in 2001 as Head of High Throughput Biology Europe. Steve led the research team which discovered BosatriaTM, an IL-5 monoclonal antibody for the treatment of severe eosinophilic asthma.
Research Interest
Endocrinology, Nephrology, Antibody Production.
